fbpx
Lesson 1, Topic 7
In Progress

Clinical Scenarios and Tips: Acute Coronary Syndrome

Lesson Progress
0% Complete
Clinical Scenarios for Acute Coronary Syndrome and Exam Tips

Clinical Scenarios for Acute Coronary Syndrome and Exam Tips

Scenario 1: STEMI in a Middle-Aged Male

Clinical Case with Question:

Mr. Smith, a 52-year-old male with a history of hypertension and hyperlipidemia, arrives at the emergency department with crushing chest pain radiating to his left arm. He is diaphoretic and appears anxious. An ECG shows ST-segment elevation in leads II, III, and aVF.

What is the immediate management for Mr. Smith, and why?

In-depth Explanation:

Mr. Smith’s presentation is consistent with ST-segment elevation myocardial infarction (STEMI), a critical condition requiring prompt reperfusion therapy to restore blood flow to the myocardium and minimize myocardial damage.

Management Strategies or Therapeutic Considerations:

Immediate Reperfusion:

  • Administer primary percutaneous coronary intervention (PCI) if within the appropriate time window.
  • If PCI is not available within 120 minutes, consider fibrinolytic therapy.

Medications:

  • Administer aspirin and a P2Y12 inhibitor (e.g., clopidogrel) to inhibit platelet aggregation.
  • Start anticoagulation (e.g., heparin) to prevent thrombus progression.
  • Provide nitroglycerin for chest pain relief, monitoring for hypotension.

Monitoring:

  • Continuous cardiac monitoring and reassessment of vital signs.
  • Prepare for potential complications such as arrhythmias or cardiogenic shock.

Scenario 2: NSTEMI in an Elderly Female

Clinical Case with Question:

Mrs. Garcia, a 75-year-old female with a history of diabetes and obesity, presents with chest discomfort and shortness of breath. Her ECG shows ST-segment depression, and cardiac biomarkers reveal elevated troponin levels.

What is the recommended management approach for Mrs. Garcia?

In-depth Explanation:

Mrs. Garcia’s symptoms and diagnostic findings indicate a non-ST-segment elevation myocardial infarction (NSTEMI). Management focuses on medical therapy and risk stratification to guide further interventions.

Management Strategies or Therapeutic Considerations:

Initial Medical Management:

  • Administer antiplatelet therapy (aspirin and clopidogrel).
  • Start anticoagulation (e.g., heparin) to reduce the risk of further thrombus formation.
  • Use beta-blockers to decrease myocardial oxygen demand and improve outcomes.

Risk Stratification:

  • Utilize the TIMI or GRACE score to assess risk and determine the need for invasive procedures.

Follow-Up Care:

  • Schedule early invasive strategy (angiography) for high-risk patients.
  • Ensure lifestyle modifications and initiate chronic therapy (e.g., statins, ACE inhibitors).

Scenario 3: Unstable Angina in a Young Female

Clinical Case with Question:

Ms. Lee, a 45-year-old female with a family history of coronary artery disease, presents to the clinic with recurrent episodes of chest pain on exertion. Her ECG is normal, and cardiac biomarkers are within normal limits.

What is the appropriate management for Ms. Lee’s condition?

In-depth Explanation:

Ms. Lee’s recurrent chest pain and normal diagnostic tests suggest unstable angina, which requires careful management to prevent progression to myocardial infarction.

Management Strategies or Therapeutic Considerations:

Medical Management:

  • Initiate antiplatelet therapy (aspirin) and consider a P2Y12 inhibitor.
  • Start beta-blockers to relieve angina and prevent future episodes.
  • Use nitrates for symptomatic relief as needed.

Lifestyle Modifications:

  • Encourage dietary changes, regular exercise, and smoking cessation.

Monitoring and Follow-Up:

  • Schedule regular follow-ups to assess symptoms and response to therapy.
  • Consider further evaluation with stress testing or coronary angiography if symptoms persist or worsen.

Tips for Board Exam Questions

1. Know the critical timeframes. Time is muscle in ACS. Key thresholds include presenting within 12 hours of symptom onset for potential reperfusion therapy, goal door-to-balloon time <90 min for STEMI patients, and 120 min door-to-needle time for fibrinolytic administration if PCI is not available.
2. Differentiate STEMI, NSTEMI, and unstable angina based on ECG and cardiac marker findings. STEMI is diagnosed by ST elevation on ECG. NSTEMI is distinguished by positive cardiac markers without ST elevation. Unstable angina demonstrates ischemic symptoms without biomarker elevation.
3. Recall guideline-recommended therapies. High yield topics include dual antiplatelet therapy, anticoagulation, reperfusion strategy selection, and appropriate use of invasive procedures. Know the medications, doses and contraindications. Strict adherence to guidelines is key to improving ACS outcomes.